Sharechat Logo

NZ building consents fall 0.4 percent in January on drop in apartments

Thursday 28th February 2013

Text too small?

New Zealand home-building consents fell last month as a drop in approvals for apartments offset gains for other types of dwellings. Auckland and Canterbury continued to account for more than half of all consents.

The number of consents fell 0.4 percent, seasonally adjusted, in January, after gaining 9.4 percent in December, according to Statistics New Zealand. Total consents were up 17.4 percent from the same month last year.

Home-building consents in Auckland jumped 60 percent to 372 in January from a year earlier, reflecting pent up demand in a city where realty firms are struggling to attract enough listings. In Canterbury, consents fell by one to 378 from a year earlier. The two regions combined made up 57 percent of the 1,312 national total.

Excluding consents for apartments, which tend to be volatile from month to month, consents rose 9.6 percent, seasonally adjusted, in January. The value of dwelling consents in January was $517 million, up 34 percent from the same month last year.

The value of non-residential building consents fell 1.4 percent to $223 million in January from a year earlier.

Earthquake-related consents in Canterbury were valued at $60 million in January, of which $28 million was for residential buildings.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors